The urinary cell cycle arrest markers tissue inhibitor of metalloproteinases 2 (TIMP2) and insulin-like growth factor-binding protein 7 (IGFBP7) [64] have been widely studied in various clinical settings and have potential implications for AKI management in critical ill patients [65, 66]. Here, TIMP2 is linked to acute kidney injury.